Healthy Living/WellnessRoche Drug Ocrelizumab Proves Effective Against Multiple Sclerosis In Three Late-Stage Studies Results of clinical trials show promise in reducing the progression of the disease, researchers say. New drug could be on the market by 2017.by Jim Algar
Healthy Living/WellnessRoche's MS Drug Ocrelizumab Shows Promising Results After Late Stage Trialsby Julienne Roman
Healthy Living/WellnessExperimental Drug Ocrelizumab Proves Successful Against Hard-To-Treat Type Of Multiple Sclerosisby Ted Ranosa
Healthy Living/WellnessFDA Issues Approval For Bayer Autoinjector For Multiple Sclerosis Therapyby Dianne Depra
Healthy Living/WellnessBreastfeeding Mothers With MS May Have Lowered Risk Of Relapseby Rina Marie Doctor
Healthy Living/WellnessStudy Shows MS Patients Are Living Longer Lives But Still 7.5 Years Shorter Than Othersby Anu Passary
Healthy Living/WellnessCreams For Eczema And Athlete's Foot Can Reverse Multiple Sclerosisby Rhodi Lee
Healthy Living/WellnessDrinking Coffee Regularly May Reduce Risk Of Multiple Sclerosisby Dianne Depra
Healthy Living/WellnessStem Cell Therapy Shows Promise in Small Multiple Sclerosis Studyby Dianne Depra
Healthy Living/WellnessFDA Approves Multiple Sclerosis Drug Lemtrada by Genzyme, Comes with Boxed Warningby Anu Passary
Leader of Furry Hackers Raided by Feds Months After Attack on Creators of Project 2025, Former Member Claims
Apple Intelligence Is Not Available on Devices Purchased in China, Especially If You Are in the Mainland